Hangzhou Biotest Biotech Co Ltd Net Asset Quality Index
Hangzhou Biotest Biotech Co Ltd net asset quality index. Hangzhou Biotest Biotech Co Ltd (688767) has a Net Asset Quality Index of 95.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.49 Billion minus total liabilities of CN¥121.73 Million yields net assets of CN¥2.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Hangzhou Biotest Biotech Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hangzhou Biotest Biotech Co Ltd (2017–2025)
Net asset quality index of Hangzhou Biotest Biotech Co Ltd from 2017 to 2025. This chart shows how Hangzhou Biotest Biotech Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the index stands at 95.1%, representing net assets of CN¥2.36 Billion against total assets of CN¥2.49 Billion CNY. See net assets of Hangzhou Biotest Biotech Co Ltd for net asset value and shareholders' equity analysis.
Hangzhou Biotest Biotech Co Ltd Net Asset Quality Index by Year (2017–2025)
Hangzhou Biotest Biotech Co Ltd net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hangzhou Biotest Biotech Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 688767 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.4% | CN¥2.37 Billion | CN¥2.54 Billion | CN¥168.17 Million | ▲ +0.7 pp |
| 2024 | 92.7% | CN¥2.41 Billion | CN¥2.60 Billion | CN¥189.79 Million | ▼ -1.1 pp |
| 2023 | 93.8% | CN¥2.42 Billion | CN¥2.58 Billion | CN¥158.82 Million | ▲ +0.7 pp |
| 2022 | 93.1% | CN¥2.56 Billion | CN¥2.75 Billion | CN¥188.92 Million | ▲ +6.4 pp |
| 2021 | 86.7% | CN¥2.11 Billion | CN¥2.43 Billion | CN¥323.36 Million | ▲ +16.8 pp |
| 2020 | 69.9% | CN¥443.02 Million | CN¥633.92 Million | CN¥190.89 Million | ▲ +10.0 pp |
| 2019 | 59.8% | CN¥125.95 Million | CN¥210.44 Million | CN¥84.50 Million | ▼ -3.6 pp |
| 2018 | 63.5% | CN¥98.15 Million | CN¥154.63 Million | CN¥56.48 Million | ▲ +1.0 pp |
| 2017 | 62.4% | CN¥79.63 Million | CN¥127.52 Million | CN¥47.88 Million | — |